Ignite Creation Date:
2024-05-06 @ 7:01 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05862337
Status:
RECRUITING
Last Update Posted:
2023-05-17
First Post:
2023-05-15
Brief Title:
Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Organization:
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Organization Data
Organization:
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Class:
INDUSTRY
Study ID:
ALTN-AK105-III-06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None